Pyrimidinylpyrazole derivatives
US5852019A · kind A · utility
8Cited by
1References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 4, 1998 |
| Grant date | Dec 22, 1998 |
| Priority date | — |
| Expiry date | Feb 4, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides a novel compound which is represented by formula (I): ##STR1## wherein preferable examples of R.sup.1 to R.sup.6 are as follows; R.sup.1 and R.sup.2 are each an alkyl group optionally substituted by a halogen atom, an amino group, a hydroxyl group, an alkoxyl group or a thiol group, a hydrogen atom, a halogen atom or an alkoxyl group; R.sup.3 is a hydrogen atom; R.sup.4 is a methyl group; R.sup.5 is a hydrogen atom or an alkyl group; and R.sup.6 is a group of the formula: ##STR2## wherein Z is a phenyl group; and has an antitumor effect.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.